Reports Q2 revenue $1.3B, consensus $1.3B. “We are pleased with our second quarter performance as strong discharge growth facilitated an increase of 9.6% in revenue and 8.9% in Adjusted EBITDA,” said President and Chief Executive Officer of Encompass Health Mark Tarr. “During the quarter we added 194 beds to our capacity and made continued progress across our key operating initiatives. We also resumed activity under our share repurchase authorization. We remain highly-optimistic about the long-term prospects of our business.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EHC:
- EHC Earnings this Week: How Will it Perform?
- Encompass Health increases share repurchase authorization
- Encompass Health increases and declares dividend on common stock and announces increase in common stock repurchase authorization
- Encompass Health increases dividend 13% to 17c per share
- Encompass Health price target raised to $100 from $95 at Truist
Questions or Comments about the article? Write to editor@tipranks.com